Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of U.S. children. Arch Pediatr Adolesc Med. 2007;161:857–64.
Article
Google Scholar
Merikangas KR, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS. Prevalence and treatment of mental disorders among US children in the 2001–2004 NHANES. Pediatrics. 2010;125(1):75–81.
Article
Google Scholar
Barkley RA. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63 Suppl 12:10–5.
Google Scholar
Nigg JT. What Causes ADHD? Understanding What Goes Wrong and Why. New York: The Guilford Press; 2006.
Google Scholar
Rauh VA, Garfinkel R, Perera FP, Andrews HF, Hoepner L, Barr DB, et al. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics. 2006;118(6):e1845–59.
Article
Google Scholar
Bouchard MF, Bellinger DC, Wright RO, Weisskopf MG. Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics. 2010;125(6):e1270–7.
Article
Google Scholar
Marks AR, Harley K, Bradman A, Kogut K, Barr DB, Johnson C, et al. Organophosphate pesticide exposure and attention in young Mexican-American children: the CHAMACOS study. Environ Health Perspect. 2010;118(12):1768–74.
Article
CAS
Google Scholar
Williams MK, Rundle A, Holmes D, Reyes M, Hoepner LA, Barr DB, et al. Changes in pest infestation levels, self-reported pesticide use, and permethrin exposure during pregnancy after the 2000–2001 U.S. Environmental Protection Agency restriction of organophosphates. Environ Health Perspect. 2008;116(12):1681–8.
Article
CAS
Google Scholar
Roberts JR, Karr CJ, Council On Environmental H. Pesticide exposure in children. Pediatrics. 2012;130(6):e1765–88.
Article
Google Scholar
Walters JK, Boswell LE, Green MK, Heumann MA, Karam LE, Morrissey BF, et al. Pyrethrin and pyrethroid illnesses in the Pacific northwest: a five-year review. Public Health Rep. 2009;124(1):149–59.
Google Scholar
Morgan MK. Children's exposures to pyrethroid insecticides at home: a review of data collected in published exposure measurement studies conducted in the United States. Int J Environ Res Public Health. 2012;9(8):2964–85.
Article
CAS
Google Scholar
Casida JE, Durkin KA. Neuroactive insecticides: targets, selectivity, resistance, and secondary effects. Annu Rev Entomol. 2013;58:99–117.
Article
CAS
Google Scholar
Gillette JS, Bloomquist JR. Differential up-regulation of striatal dopamine transporter and alpha-synuclein by the pyrethroid insecticide permethrin. Toxicol Appl Pharmacol. 2003;192(3):287–93.
Article
CAS
Google Scholar
Elwan MA, Richardson JR, Guillot TS, Caudle WM, Miller GW. Pyrethroid pesticide-induced alterations in dopamine transporter function. Toxicol Appl Pharmacol. 2006;211(3):188–97.
Article
CAS
Google Scholar
Bloomquist JR, Barlow RL, Gillette JS, Li W, Kirby ML. Selective effects of insecticides on nigrostriatal dopaminergic nerve pathways. Neurotoxicology. 2002;23(4–5):537–44.
Article
CAS
Google Scholar
Madras BK, Miller GM, Fischman AJ. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1397–409.
Article
CAS
Google Scholar
Raskin LA, Shaywitz SE, Shaywitz BA, Anderson GM, Cohen DJ. Neurochemical correlates of attention deficit disorder. Pediatr Clin North Am. 1984;31(2):387–96.
Article
CAS
Google Scholar
Burns CJ, McIntosh LJ, Mink PJ, Jurek AM, Li AA. Pesticide exposure and neurodevelopmental outcomes: review of the epidemiologic and animal studies. J Toxicol Environ Health B Crit Rev. 2013;16(3–4):127–283.
Article
CAS
Google Scholar
Eriksson P, Fredriksson A. Neurotoxic effects of two different pyrethroids, bioallethrin and deltamethrin, on immature and adult mice: changes in behavioral and muscarinic receptor variables. Toxicol Appl Pharmacol. 1991;108(1):78–85.
Article
CAS
Google Scholar
Eriksson P, Nordberg A. Effects of two pyrethroids, bioallethrin and deltamethrin, on subpopulations of muscarinic and nicotinic receptors in the neonatal mouse brain. Toxicol Appl Pharmacol. 1990;102(3):456–63.
Article
CAS
Google Scholar
Talts U, Fredriksson A, Eriksson P. Changes in behavior and muscarinic receptor density after neonatal and adult exposure to bioallethrin. Neurobiol Aging. 1998;19(6):545–52.
Article
CAS
Google Scholar
Ahlbom J, Fredriksson A, Eriksson P. Neonatal exposure to a type-I pyrethroid (bioallethrin) induces dose–response changes in brain muscarinic receptors and behaviour in neonatal and adult mice. Brain Res. 1994;645(1–2):318–24.
Article
CAS
Google Scholar
Richardson JR, Taylor MM, Shalat SL, Guillot TS, Caudle WM, Hossain MM, et al. Developmental pesticide exposure reproduces features of attention-deficit hyperactivity disorder. FASEB J. 2015;29:1960–72.
Article
CAS
Google Scholar
Lazarini CA, Florio JC, Lemonica IP, Bernardi MM. Effects of prenatal exposure to deltamethrin on forced swimming behavior, motor activity, and striatal dopamine levels in male and female rats. Neurotoxicol Teratol. 2001;23(6):665–73.
Article
CAS
Google Scholar
Oulhote Y, Bouchard MF. Urinary metabolites of organophosphate and pyrethroid pesticides and behavioral problems in canadian children. Environ Health Perspect. 2013;121(11–12):1378–84.
Google Scholar
Quiros-Alcala L, Mehta S, Eskenazi B. Pyrethroid Pesticide Exposure and Parental Report of Learning Disability and Attention Deficit/Hyperactivity Disorder in U.S. Children: NHANES 1999–2002. Environ Health Perspect. 2014;122(12):1336–42.
CAS
Google Scholar
Data Documentation, Codebook, and Frequencies: Urinary Priority Pesticides (Non-Persistent Pesticide Metabolites). [http://www.cdc.gov/nchs/nhanes/nhanes2001-2002/l26PP_B.htm#Description_of_Laboratory_Methodology]
Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry. 2000;39(1):28–38.
Article
CAS
Google Scholar
Bravo M, Ribera J, Rubio-Stipec M, Canino G, Shrout P, Ramirez R, et al. Test-retest reliability of the Spanish version of the Diagnostic Interview Schedule for Children (DISC-IV). J Abnorm Child Psychol. 2001;29(5):433–44.
Article
CAS
Google Scholar
Canino G, Shrout PE, Rubio-Stipec M, Bird HR, Bravo M, Ramirez R, et al. The DSM-IV rates of child and adolescent disorders in Puerto Rico: prevalence, correlates, service use, and the effects of impairment. Arch Gen Psychiatry. 2004;61(1):85–93.
Article
Google Scholar
van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study. Clin Psychol Psychother. 2012;19(3):270–8.
Article
Google Scholar
Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000;157(5):816–8.
Article
CAS
Google Scholar
Barr DB, Olsson AO, Wong LY, Udunka S, Baker SE, Whitehead RD, et al. Urinary concentrations of metabolites of pyrethroid insecticides in the general U.S. population: National Health and Nutrition Examination Survey 1999–2002. Environ Health Perspect. 2010;118(6):742–8.
Article
CAS
Google Scholar
Pastor PN, Reuben CA. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004–2006. Vital Health Stat. 2008;10(237):1–14.
Google Scholar
Lingineni RK, Biswas S, Ahmad N, Jackson BE, Bae S, Singh KP. Factors associated with attention deficit/hyperactivity disorder among US children: results from a national survey. BMC Pediatr. 2012;12:50.
Article
Google Scholar
Froehlich TE, Lanphear BP, Auinger P, Hornung R, Epstein JN, Braun J, et al. Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder. Pediatrics. 2009;124(6):e1054–63.
Article
Google Scholar
Braun JM, Kahn RS, Froehlich TE, Auinger P, Lanphear BP. Exposures to Environmental Toxicants and Attention Deficit Hyperactivity Disorder in U.S. Children. Environ Health Perspect. 2006;114(12):1904–9.
Google Scholar
Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 2005;113(2):192–200.
Article
CAS
Google Scholar
Desquilbet L, Mariotti F. Dose–response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29(9):1037–57.
Google Scholar
Froehlich TE, Anixt JS, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman RC. Update on environmental risk factors for attention-deficit/hyperactivity disorder. Curr Psychiatry Rep. 2011;13(5):333–44.
Article
Google Scholar
Attfield KR, Hughes MD, Spengler JD, Lu C. Within- and between-child variation in repeated urinary pesticide metabolite measurements over a 1-year period. Environ Health Perspect. 2014;122(2):201–6.
Google Scholar
Wacholder S, Hartge P, Lubin JH, Dosemeci M. Non-differential misclassification and bias towards the null: a clarification. Occup Environ Med. 1995;52(8):557–8.
Article
CAS
Google Scholar
Jurek AM, Greenland S, Maldonado G, Church TR. Proper interpretation of non-differential misclassification effects: expectations vs observations. Int J Epidemiol. 2005;34(3):680–7.
Article
Google Scholar
Epstein JN, Langberg JM, Lichtenstein PK, Mainwaring BA, Luzader CP, Stark LJ. Community-wide intervention to improve the attention-deficit/hyperactivity disorder assessment and treatment practices of community physicians. Pediatrics. 2008;122(1):19–27.
Article
Google Scholar